Skip to content

System 37 Home Uterine Activity Monitor

by Matria Healthcare, Inc.

PMA P920038

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P920038↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPRL NumberP920038 Date29 Sep 1995DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
System 37 Home Uterine Activity Monitoring System
Generic Name
Home uterine activity monitor
PMA Number
FDA Product Code
LQK
Device Class
Class II
Regulation
21 CFR Part 884.2730
Advisory Committee
Obstetrics/Gynecology
FDA Decision
APRL

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The System 37 Home Uterine Activity Monitor is a Class II medical device designed for continuous, non-invasive monitoring of uterine contractions and fetal heart rate at home. It provides real-time data to assess labor progression and fetal well-being, supporting clinical decision-making in obstetric care.

This device is supplied as a reusable system with disposable sensors and is intended for use in home settings under medical supervision. It requires FDA approval (PMA P920038) and is classified under regulation number 884.2730 for obstetrics/gynecology applications. Proper storage and maintenance are essential to ensure accurate monitoring and compliance with regulatory standards.

Other devices from Matria Healthcare, Inc.

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the SYSTEM 37 Home Uterine Activity Monitoring System, and how does it differ from traditional hospital-based monitoring?

    The SYSTEM 37 is designed for continuous, non-invasive monitoring of uterine contractions and fetal heart rate in a home setting, allowing clinicians to track labor progression and fetal well-being remotely. Unlike hospital-based monitors, it enables real-time data transmission from home, supporting medical supervision outside the clinical environment while maintaining accuracy for obstetric decision-making.

  • Is the SYSTEM 37 reusable, and if so, what components are disposable?

    Yes, the SYSTEM 37 is supplied as a reusable system, but it requires disposable sensors for each use. This design balances cost efficiency with hygiene, ensuring accurate monitoring while minimizing cross-contamination risks between patients.

  • What regulatory approval does the SYSTEM 37 hold, and how does that affect its use?

    The SYSTEM 37 holds FDA Premarket Approval (PMA P920038), meaning it has undergone rigorous review to demonstrate safety and effectiveness for its intended use in obstetrics/gynecology (regulation 884.2730). This approval ensures compliance with U.S. regulatory standards for home uterine monitoring under medical supervision.

  • How should the SYSTEM 37 be stored to maintain its functionality and accuracy?

    Proper storage is critical for performance and compliance. While exact storage conditions aren’t detailed here, the manufacturer emphasizes maintenance protocols to preserve accuracy—likely including protection from moisture, extreme temperatures, and physical damage. Always follow the included instructions to ensure reliable monitoring.